Wellington Hospital, also known as Wellington Regional Hospital, is the main hospital in Wellington, New Zealand, located south of the city centre in the suburb of Newtown. It is the main hospital run by Capital & Coast District Health Board, which serves Wellington City, Porirua and the Kapiti Coast District.

During the past decade, Wellington Hospital conducted 83 clinical trials. In the 10-year time frame, 83 clinical trials started and 41 clinical trials were completed, i.e. on average, 49.4% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 26 clinical trials were completed. i.e. 130% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Wellington Hospital" #1 sponsor was "Australian and New Zealand Intensive Care Research Centre" with 10 trials, followed by "Shire" with 6 trials sponsored, "Trans Tasman Radiation Oncology Group" with 6 trials sponsored, "BeiGene" with 5 trials sponsored and "Gilead Sciences" with 5 trials sponsored. Other sponsors include 94 different institutions and companies that sponsored additional 74 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wellington Hospital" #1 collaborator was "National Health and Medical Research Council, Australia" with 13 trials as a collaborator, "Australian and New Zealand Intensive Care Society Clinical Trials Group" with 5 trials as a collaborator, "Health Research Council, New Zealand" with 5 trials as a collaborator, "Abbott" with 4 trials as a collaborator and "Baxter Healthcare Corporation" with 4 trials as a collaborator. Other collaborators include 143 different institutions and companies that were collaborators in the rest 127 trials.

According to Clinical.Site data, the most researched conditions in "Wellington Hospital" are "Coronary Artery Disease" (9 trials), "Crohn's Disease" (6 trials), "Ulcerative Colitis" (6 trials), "Sepsis" (4 trials) and "Critically Ill" (3 trials). Many other conditions were trialed in "Wellington Hospital" in a lesser frequency.

Most popular intervention types in "Wellington Hospital" are "Drug" (88 trials), "Other" (22 trials), "Device" (19 trials), "Biological" (8 trials) and "Procedure" (8 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (36 trials), "Filgotinib" (5 trials), "Ontamalimab" (4 trials), "ALS-008176" (2 trials) and "Aspirin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Wellington Hospital" are 122 trials for "All" genders, 6 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Wellington Hospital". undefined are not yet recruiting, 18 are recruiting, 18 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 78 completed trials in Wellington Hospital, undefined suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in Wellington Hospital, 9 "Phase 1" clinical trials were conducted, 29 "Phase 2" clinical trials and 62 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 27 trials that are defined as “Not Applicable".